Ranbaxy Laboratories announced on Wednesday that it has signed a consent decree with the US Food and Drug Administration (FDA) on charges of violations of current goods manufacturing practices (CGMP) at two of its facilities.
Nifty levels for tomorrow 23 December
This is strong second day when market goes up, boosted by strong opening across European peers and late afternoon gains in realty, consumer durables and power stocks. Sensex ended at 15,811.62, higher by 126.41 points or 0.81% while Nifty edged 40.70 points or 0.87% higher to shut shop at was at 4,733.85.
Ranbaxy Laboratories announced on Wednesday that it has signed a consent decree with the US Food and Drug Administration (FDA) on charges of violations of current goods manufacturing practices (CGMP) at two of its facilities.
Ranbaxy Laboratories announced on Wednesday that it has signed a consent decree with the US Food and Drug Administration (FDA) on charges of violations of current goods manufacturing practices (CGMP) at two of its facilities.
0 comments:
Post a Comment